ABSTRACT
The application of 18 F-FDG PET-CT in the diagnosis and treatment of nasopharyngeal carcinoma includes early diagnosis,clinical staging,contouring target volume,predicting the sensitivity of tumors to radiotherapy and effect evaluation,and monitoring the residual and recurrence.However,18 F-FDG uptake of tumor cells is under the influence of various factors,so false positive and false negative are unavoidable.Therefore it is need to develop more specific tracer agent in order to improve the accuracy of diagnosis and treatment,as well as to carry out multicenter clinical trial to identify the correlation of standardized uptake value (SUV)and radiation target volume.
ABSTRACT
During radiation for head and neck cancers,part of parotids are contained in planning target volume(PTV),which lead to parotids receiving radiation as the same as PTV.Radiation for head and neck cancers will influence the parotids.In the period of radiation,many factors will influence parotids,such as age,primary parotid volume,V10-40,weight and mean radiation dose et al.These factors will result in that the parotid volume reduces nearly 50％ and moves toward the middle line of the body.As a result,the real dose of the parotid receiving is higher than prescription dose.The excretion function of the parotid will be severely damaged after radiation,which will lead to xerostomia and influence the quality of patients life.
ABSTRACT
Proton magnetic resonance spectroscopy (HMRS) is the only way to study noninvasively the metabolic and biochemical signature of the human tissues and organs.It can also quantify the metabolites within the volume of interest.The metabolic information about the lesions provided by the HMRS can greatly improve the diagnostic,grading accuracy,treatment planning such as target delineation and posttreatment follow-up of the glioma.
ABSTRACT
Objective To evaluate the prognostic value of the expression of epidermal growth factor receptor (EGFR) and nm23 in patients with nasopharyngeal carcinoma (NPC). Methods From 2003 to 2006, 127 NPC patients who had undergone biopsy before radiotherapy were reviewed retrospectively. All patients received intensity-modulated radiotherapy using 6 MV X-rays combined with platinum-based chemotherapy. Immunohistochemistry SP method was adopted to detect the expression of EGFR and nm23 in NPC biopsy specimens . The relationship between the expression of EGFR and nm23 and survival was analyzed. Results The positive rate of EGFR and nm23 were 80.3% and 47. 2% respectively. The nm23expression was correlated with distant metastasis (χ2=7.03, P = 0. 008 ). The 5-year estimated local control, over-all survival (OS) and disease-free survival (DFS) were 58.3% ,53.5% and 46. 5%. Patients with negative expression of EGFR had a significantly better 5-year OS, DFS (χ2=8.23, P=0.004;χ2=5.25,P=0.022) than those with positive expression. Patients with positive expression of nm23 had a significantly higher 5-year OS (χ2=15.68, P = 0. 000) and DFS (χ2=14. 85, P = 0. 000) than those with negative expression. The clinical stage, EGFR and nm23 expression were independent prognostic factors shown by Cox proportional hazard model (χ2=23.03, 18.33, 39.92, P= 0.000, 0.000, 0.000).Conclusions The EFGR and nm23 expression were correlated with the prognosis in NPC patients.
ABSTRACT
Radiotherapy is one of the most important treatments for glioma; however its therapeutic effect is unsatisfying. Timing, accurate target outlining, a total dose higher than 60Gy, conformal modulating radiotherapy and combined chemotherapy and targeted therapy are important factors in improving the outcome of radiotherapy.
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the effects of c-jun on hCG-induced testosterone secretion in isolated rat Leydig cells by antisense oligodeoxynucleotides(ASODNs).</p><p><b>METHODS</b>c-jun ASODNs were used to antagonise the effects of c-jun, hCG was used to induce the testosterone secretion of LC cultured in vitro and testosterone was measured by radioimmunoassay.</p><p><b>RESULTS</b>The testosterone secretion of LC in vitro could be induced by hCG, which was a good model for the functional study of LC. c-jun ASODNs decreased the hCG-induced testosterone secretion of LC in a dose-dependent manner(P < 0.05).</p><p><b>CONCLUSION</b>It is suggested that c-jun proto-oncogene enhances the testosterone secretion of LC.</p>